This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John O. Fleming, MD; Stephen A. Stohlman, PhD; Leslie P. Weiner, MD
USC School of Medicine McKibben Annex, Room 142 2025 Zonal Ave Los Angeles, CA 90033

Arch Neurol. 1982;39(7):455.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Madden et al (ARCHIVES 1981;38:209-210) presented an interesting and careful study of antibodies to coronaviruses in the sera of patients with multiple sclerosis (MS) and controls. However, for a number of reasons we do not agree that their data, based entirely on a serologic survey, warrants the conclusion that "coronaviruses do not appear to be associated with the cause of MS."

First, as the authors pointed out, coronaviruses are ubiquitous in man. This fact accounts for the high incidence of seropositivity in controls and may make it difficult to identify patients with disease, ie, nervous system involvement, against the background of general seropositivity. This is the case, for example, with conditions such as progressive multifocal leukoencephalopathy¹ in which both affected patient and control populations have a high percentage of persons with antibody to the relevant virus, thus making diagnosis on serologic grounds impossible.

Second, analysis of . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?